WallStSmart

MiniMed Group, Inc. Common Stock (MMED)vsPrivia Health Group Inc (PRVA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MiniMed Group, Inc. Common Stock generates 36% more annual revenue ($2.89B vs $2.12B). PRVA leads profitability with a 108.0% profit margin vs -7.3%. PRVA earns a higher WallStSmart Score of 48/100 (D+).

MMED

Hold

37

out of 100

Grade: F

Growth: 5.3Profit: 3.5Value: 5.0Quality: 5.0

PRVA

Hold

48

out of 100

Grade: D+

Growth: 8.7Profit: 5.5Value: 3.0Quality: 8.0
Piotroski: 4/9Altman Z: 3.09
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for MMED.

PRVASignificantly Overvalued (-156.5%)

Margin of Safety

-156.5%

Fair Value

$8.42

Current Price

$20.54

$12.12 premium

UndervaluedFair: $8.42Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MMED0 strengths · Avg: 0/10

No standout strengths identified

PRVA5 strengths · Avg: 9.6/10
Profit MarginProfitability
108.0%10/10

Keeps 108 of every $100 in revenue as profit

EPS GrowthGrowth
132.8%10/10

Earnings expanding 132.8% YoY

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.0910/10

Safe zone — low bankruptcy risk

Revenue GrowthGrowth
17.4%8/10

17.4% revenue growth

Areas to Watch

MMED4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Operating MarginProfitability
1.4%3/10

Operating margin of 1.4%

Free Cash FlowQuality
$-53.00M2/10

Negative free cash flow — burning cash

PRVA3 concerns · Avg: 2.7/10
Return on EquityProfitability
4.0%3/10

ROE of 4.0% — below average capital efficiency

Operating MarginProfitability
2.1%3/10

Operating margin of 2.1%

P/E RatioValuation
116.8x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : MMED

Revenue growth of 13.1% demonstrates continued momentum.

Bull Case : PRVA

The strongest argument for PRVA centers on Profit Margin, EPS Growth, Debt/Equity. Profitability is solid with margins at 108.0% and operating margin at 2.1%. Revenue growth of 17.4% demonstrates continued momentum.

Bear Case : MMED

The primary concerns for MMED are EPS Growth, Return on Equity, Operating Margin.

Bear Case : PRVA

The primary concerns for PRVA are Return on Equity, Operating Margin, P/E Ratio. A P/E of 116.8x leaves little room for execution misses.

Key Dynamics to Monitor

MMED profiles as a turnaround stock while PRVA is a growth play — different risk/reward profiles.

PRVA is growing revenue faster at 17.4% — sustainability is the question.

PRVA generates stronger free cash flow (126M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

PRVA scores higher overall (48/100 vs 37/100), backed by strong 108.0% margins and 17.4% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MiniMed Group, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.

Privia Health Group Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Privia Health Group, Inc. is a population health technology and medical practice management company in the United States.

Visit Website →

Want to dig deeper into these stocks?